Learning objectives: Identify individuals with hypothyroidism that could benefit from treatment with LT4 and LT3.

Interpret the impact of deiodinase polymorphism on treatment of hypothyroidism.

Session date: 
11/27/2018 - 12:00pm to 1:00pm CST
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Antonio Bianco, MD, PhD